Paradigm Clinical Research
Kurt Mussina is an accomplished executive with extensive experience in clinical research and business development. Currently serving as the Chief Executive Officer at Paradigm Clinical Research since May 2022, Mussina has also held the position of Strategic Advisor at SCORR Marketing since June 2016. Previously, Mussina was President of Frenova Renal Research and Senior Vice President of the Global Medical Office at Fresenius Medical Care, where significant improvements were made in business performance, including achieving over a 40% operating margin and expanding the number of active studies. Other notable roles include President at Triangle Research Labs and Senior Vice President at Aptiv Solutions, where Mussina led the North American sales organization to exceed expectations. Education includes an MBA from Duke University's Fuqua School of Business and a BS in Chemistry from Montclair State University, along with participation in Harvard Business School's Top Executive Program.
This person is not in any teams
This person is not in any offices
Paradigm Clinical Research
Paradigm Clinical Research is a long-standing, professionally managed clinical research site business. We operate wholly owned sites that provide our client sponsors with access to diverse and often under-represented patient populations and investigators. We are uniquely positioned to deliver superior value by continuously lowering barriers to study participation for patients and investigators. Our mission is to enrich the lives of those we serve by offering opportunity to advance the human condition through participation in brilliantly executed clinical trials. As an employer of choice, Paradigm actively encourages and supports professional growth, provides a market-leading benefits package, and promotes a winning culture.
Employees
11-50